We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJEFI.L Regulatory News (JEFI)

  • There is currently no data for JEFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update research from QuotedData

20 Jul 2021 11:01

RNS Number : 8319F
Jupiter Emerging & Frontier Inc.Tst
20 July 2021
 

Jupiter Emerging & Frontier Income - Update research from QuotedData

1st June 2021

 

Out in front

 

In both total net asset value (NAV) and share price return terms, Jupiter Emerging & Frontier Income (JEFI) has been the pacesetter within its peer group since the November 2020 vaccine announcements. Manager Ross Teverson and the team's long-held view that stocks were priced more attractively outside of China has been paying off, led by its Taiwan-based holdings in particular.

 

JEFI's bottom-up approach, which combines value and growth elements, has matched well with the shift away from growth stocks. A portfolio comprising predominantly of stocks with above-average dividend yields, the absence of reliance on China and India, and a mandate that allows investments into both emerging (EM) and frontier (FM) markets makes JEFI a unique proposition (see page 14). Despite its smaller size, it is trading at one of the tightest discounts within its peer group. A return to the pre-pandemic premium share price to NAV rating would allow JEFI to grow by raising capital and broaden its attraction to institutional investors.

 

Full research:

https://quoteddata.com/research/jupiter-emerging-frontier-income-front/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Jupiter Emerging & Frontier Income Trust and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAURRRRARUBUAR
Date   Source Headline
13th Jun 20224:26 pmRNSResult of Meeting
13th Jun 20221:10 pmRNSNet Asset Value(s)
13th Jun 20227:30 amRNSStatement re. Suspension
10th Jun 202210:12 amRNSNet Asset Value(s)
9th Jun 20225:35 pmRNSHolding(s) in Company
9th Jun 202210:37 amRNSNet Asset Value(s)
8th Jun 202211:22 amRNSNet Asset Value(s)
7th Jun 202210:30 amRNSNet Asset Value(s)
6th Jun 20225:30 pmRNSJupiter Emerging & Frontier Income Trust
6th Jun 202210:55 amRNSNet Asset Value(s)
1st Jun 202211:26 amRNSNet Asset Value(s)
31st May 20225:32 pmRNSTotal Voting Rights
31st May 20229:50 amRNSNet Asset Value(s)
30th May 20229:30 amRNSNet Asset Value(s)
27th May 202210:33 amRNSNet Asset Value(s)
26th May 20229:22 amRNSNet Asset Value(s)
25th May 20229:27 amRNSNet Asset Value(s)
24th May 20222:59 pmRNSDividend Declaration
24th May 202210:06 amRNSNet Asset Value(s)
23rd May 202210:45 amRNSNet Asset Value(s)
20th May 20229:40 amRNSNet Asset Value(s)
19th May 20229:24 amRNSNet Asset Value(s)
18th May 202210:16 amRNSNet Asset Value(s)
17th May 202210:21 amRNSNet Asset Value(s)
16th May 202210:14 amRNSNet Asset Value(s)
13th May 20229:43 amRNSNet Asset Value(s)
12th May 202210:48 amRNSNet Asset Value(s)
12th May 20227:00 amRNSPublication of General Meeting circular
11th May 20229:18 amRNSNet Asset Value(s)
10th May 202210:16 amRNSNet Asset Value(s)
9th May 202210:04 amRNSNet Asset Value(s)
6th May 20229:53 amRNSNet Asset Value(s)
5th May 20229:42 amRNSNet Asset Value(s)
4th May 202211:15 amRNSNet Asset Value(s)
3rd May 202211:01 amRNSNet Asset Value(s)
29th Apr 20225:24 pmRNSTotal Voting Rights
29th Apr 20229:44 amRNSNet Asset Value(s)
28th Apr 202210:11 amRNSNet Asset Value(s)
27th Apr 202210:07 amRNSNet Asset Value(s)
26th Apr 20229:49 amRNSNet Asset Value(s)
25th Apr 20229:50 amRNSNet Asset Value(s)
22nd Apr 20229:35 amRNSNet Asset Value(s)
21st Apr 20229:44 amRNSNet Asset Value(s)
20th Apr 20229:58 amRNSNet Asset Value(s)
19th Apr 202212:25 pmRNSNet Asset Value(s)
14th Apr 202210:26 amRNSNet Asset Value(s)
14th Apr 20227:00 amRNSCompany Update
13th Apr 202212:34 pmRNSDirector/PDMR Shareholding
13th Apr 202212:11 pmRNSDirector/PDMR Shareholding
13th Apr 20229:35 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.